ARS Pharmaceuticals (SPRY) Inventory (2024 - 2026)

ARS Pharmaceuticals has disclosed Inventory across 3 years of filings, most recently posting $8.8 million for Q1 2026.

• Inventory for Q1 2026 came in at $8.8 million, up 21.28% year-over-year; the trailing twelve-month figure through Mar 2026 was $8.8 million (up 21.28% YoY), and the FY2025 annual result was $8.4 million, up 60.57% from the prior year.
• Inventory came in at $8.8 million for Q1 2026 at ARS Pharmaceuticals, up from $8.4 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $8.8 million in Q1 2026 to a low of $715000.0 in Q3 2024.
• The 3-year median for Inventory is $7.8 million (2025), against an average of $6.7 million.
• Across the five-year window, Inventory surged 988.39% in 2025 and grew 21.28% in 2026, its largest moves.
• ARS Pharmaceuticals' Inventory stood at $5.2 million in 2024, then surged by 60.57% to $8.4 million in 2025, then grew by 5.35% to $8.8 million in 2026.
• The last three Inventory figures came in at $8.8 million (Q1 2026), $8.4 million (Q4 2025), and $7.8 million (Q3 2025), per Business Quant data.